Chemical Name: 5-(2-Ethoxy-5-((4-methylpiperazin-1-yl-2,2,3,3,5,5,6,6-d8)sulfonyl)phenyl)-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
Smiles: CCOC1=C(C(NC2=C3N(C)N=C2CCC)=NC3=O)C=C([S](=O)(N4C([2H])([2H])C([2H])([2H])N(C)C([2H])([2H])C4([2H])[2H])=O)C=C1
Inchi: InChI=1/C17H26ClN.ClH/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14;/h6-9,13,16H,5,10-12H2,1-4H3;1H/i1D3,2D3,13D;
Quantification of active pharmaceutical ingredient and impurities in sildenafil citrate obtained from the Internet
Michael A Veronin , Mohammad T Nutan , Uday Krishna Reddy Dodla
Ther Adv Drug Saf. 2014 Oct;5(5):180-9
Validated Methods for Determination of Sildenafil Citrate in The Presence of its Potential Impurities
A.E. El-Gindy , E. Shokry M. Farouk , L. Abd El-Aziz
J Biomed Sci and Res., Vol 2 (4), 2010,262-278
Validated LC method for sildenafil citrate related substances and its potential oxidative degradation product
A.Nageswari, P.Surya Prakash Rao, B.Gowri Sankar Rao, B.Satyanarayana , M.Saravanan , V.Ranga Reddy , Mukkanti
ACAIJ, 10(10) 2011 [683-690]
Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC
N Daraghmeh, M Al-Omari, A.ABadwan, A.M.YJaber
Journal of Pharmaceutical and Biomedical Analysis Volume 25, Issues 3–4, June 2001, Pages 483-492